{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:48:21Z","timestamp":1785880101173,"version":"3.56.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471776"],"award-info":[{"award-number":["82471776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373892"],"award-info":[{"award-number":["82373892"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cytogfr.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T22:09:00Z","timestamp":1782079740000},"page":"88-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Shared and context-specific mechanisms of T cell exhaustion in chronic viral infections and cancer: Transcriptional, metabolic, epigenetic, and therapeutic perspectives"],"prefix":"10.1016","volume":"90","author":[{"given":"Wencan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.14309\/ajg.0000000000001575","article-title":"Hepatitis B virus infection and extra-hepatic manifestations: a systemic disease","volume":"117","author":"Cacoub","year":"2022","journal-title":"Am. J. Gastroenterol."},{"issue":"3 1","key":"10.1016\/j.cytogfr.2026.06.004_bib2","article-title":"The hepatitis C virus: overview","volume":"26","author":"Purcell","year":"1997","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.06.004_bib5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nm757","article-title":"Lethal H5N1 influenza viruses escape host anti-viral cytokine responses","volume":"8","author":"Seo","year":"2002","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2022.104127","article-title":"The Spanish flu","volume":"51","author":"Berche","year":"2022","journal-title":"Presse Med."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.06.004_bib9","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/infdis\/jiab061","article-title":"Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19","volume":"223","author":"Chen","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.06.004_bib10","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1627824","article-title":"Cytomegalovirus and Epstein-Barr Infections: prevalence and Impact on Patients with Hematological Diseases","volume":"2020","author":"de Melo Silva","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib12","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection","volume":"138","author":"Virgin","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/imcb.12338","article-title":"Dysregulation of humoral immunity in chronic infection","volume":"98","author":"Cooper","year":"2020","journal-title":"Immunol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011794","article-title":"Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2","volume":"20","author":"Ware","year":"2024","journal-title":"PLoS. Pathog."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","article-title":"Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses","volume":"53","author":"Zhou","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41385-020-00373-4","article-title":"Influenza- and MCMV-induced memory CD8 T cells control respiratory vaccinia virus infection despite residence in distinct anatomical niches","volume":"14","author":"Welten","year":"2021","journal-title":"Mucosal Immunol."},{"issue":"8025","key":"10.1016\/j.cytogfr.2026.06.004_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-024-07748-8","article-title":"Immunological memory diversity in the human upper airway","volume":"632","author":"Ramirez","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037804","article-title":"Defining the Molecular Hallmarks of T-Cell Memory","volume":"14","author":"Zebley","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-immunol-032712-095954","article-title":"Memory T cell subsets, migration patterns, and tissue residence","volume":"31","author":"Mueller","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"33","key":"10.1016\/j.cytogfr.2026.06.004_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo5871","article-title":"The evolving role of tissue-resident memory T cells in infections and cancer","volume":"8","author":"Yenyuwadee","year":"2022","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib22","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037978","article-title":"Influenza-Specific Lung-Resident Memory CD8(+) T Cells","volume":"13","author":"van de Wall","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.06.004_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","article-title":"Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes","volume":"187","author":"Gallimore","year":"1998","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.chom.2023.04.015","article-title":"Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox","volume":"31","author":"Adamo","year":"2023","journal-title":"Cell. Host Microbe"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag2031","article-title":"Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity","volume":"2","author":"Sl\u00fctter","year":"2017","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006810","article-title":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection","volume":"14","author":"Schmidt","year":"2018","journal-title":"PLoS. Pathog."},{"issue":"20","key":"10.1016\/j.cytogfr.2026.06.004_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173489","article-title":"Epstein-Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues","volume":"9","author":"Kirchmeier","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021040575","article-title":"PD-L1 overexpression in the lungs of subjects who died from COVID-19: are we on the way to understanding the immune system exhaustion induced by SARS-CoV-2?","volume":"32","author":"Ronchi","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","article-title":"TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision","volume":"51","author":"Chen","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib31","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41467-020-16219-3","article-title":"Tcf1(+) cells are required to maintain the inflationary T cell pool upon MCMV infection","volume":"11","author":"Welten","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fimmu.2019.00169","article-title":"The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib33","article-title":"Terminally exhausted CD8(+) T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology","volume":"16","author":"Guo","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib35","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1038\/s41467-024-53262-w","article-title":"Spatial dynamics of CD39(+)CD8(+) exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer","volume":"15","author":"Tanoue","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41467-022-35238-w","article-title":"A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer","volume":"14","author":"Tietscher","year":"2023","journal-title":"Nat. Commun."},{"issue":"8059","key":"10.1016\/j.cytogfr.2026.06.004_bib37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41586-024-08451-4","article-title":"Precursors of exhausted T cells are pre-emptively formed in acute infection","volume":"640","author":"Chu","year":"2025","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.cytogfr.2026.06.004_bib38","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.4049\/jimmunol.1403004","article-title":"Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion-like Phenotype","volume":"195","author":"Erickson","year":"2015","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.cytogfr.2026.06.004_bib39","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8(+) T cells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"issue":"7534","key":"10.1016\/j.cytogfr.2026.06.004_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib41","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.1402607","article-title":"Id3 Controls Cell Death of 2B4+ Virus-Specific CD8+ T Cells in Chronic Viral Infection","volume":"195","author":"Menner","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/v15051141","article-title":"The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection","volume":"15","author":"Apol \u00c1","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"issue":"7930","key":"10.1016\/j.cytogfr.2026.06.004_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41586-022-05257-0","article-title":"PD-1 combination therapy with IL-2 modifies CD8(+) T cell exhaustion program","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2026.06.004_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111957","article-title":"Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection","volume":"142","author":"Awadasseid","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PLoS. Pathog."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20142237","article-title":"Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells","volume":"212","author":"Odorizzi","year":"2015","journal-title":"J. Exp. Med."},{"issue":"1_ement","key":"10.1016\/j.cytogfr.2026.06.004_bib48","article-title":"PD-1 Signals are Critical for Homeostatic Maintenance of Memory CD8 T Cells","volume":"204","author":"Sarkar","year":"2020","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cytogfr.2026.06.004_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107827","article-title":"The PD-1 pathway regulates development and function of memory CD8(+) T cells following respiratory viral infection","volume":"31","author":"Pauken","year":"2020","journal-title":"Cell. Rep."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.06.004_bib50","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41590-024-01961-3","article-title":"Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control","volume":"25","author":"Weiss","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218109","article-title":"Harnessing IL-2 without feeding the enemy: modern strategies to overcome regulatory T cell expansion in cancer immunotherapy","volume":"635","author":"Ma","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cytogfr.2025.10.009","article-title":"Natural killers or natural regulators? Dual roles of NK cells in checkpoint immunotherapy","volume":"86","author":"Ma","year":"2025","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"6316","key":"10.1016\/j.cytogfr.2026.06.004_bib53","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.06.004_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104258","article-title":"Understanding and overcoming the resistance of cancer to PD-1\/PD-L1 blockade","volume":"145","author":"Shergold","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib57","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.cytogfr.2026.06.004_bib58","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"R.-. Investigators, Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib60","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib61","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J. Hepatol."},{"issue":"7764","key":"10.1016\/j.cytogfr.2026.06.004_bib62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004251","article-title":"T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection","volume":"10","author":"Buggert","year":"2014","journal-title":"PLoS. Pathog."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","article-title":"The transcription factor NFAT promotes exhaustion of activated CD8\u207a T cells","volume":"42","author":"Martinez","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib65","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.immuni.2017.11.021","article-title":"Transcription Factor IRF4 Promotes CD8(+) T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection","volume":"47","author":"Man","year":"2017","journal-title":"Immunity"},{"issue":"25","key":"10.1016\/j.cytogfr.2026.06.004_bib66","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7749","key":"10.1016\/j.cytogfr.2026.06.004_bib67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","article-title":"NR4A transcription factors limit CAR T cell function in solid tumours","volume":"567","author":"Chen","year":"2019","journal-title":"Nature"},{"issue":"105","key":"10.1016\/j.cytogfr.2026.06.004_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado3032","article-title":"Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate","volume":"10","author":"Huang","year":"2025","journal-title":"Sci. Immunol."},{"issue":"7764","key":"10.1016\/j.cytogfr.2026.06.004_bib69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1(+)PD-1(+)CD8(+) T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"issue":"6735","key":"10.1016\/j.cytogfr.2026.06.004_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn2337","article-title":"KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection","volume":"387","author":"Fagerberg","year":"2025","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cytogfr.2026.06.004_bib72","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.immuni.2023.11.005","article-title":"Stat5 opposes the transcription factor Tox and rewires exhausted CD8(+) T cells toward durable effector-like states during chronic antigen exposure","volume":"56","author":"Beltra","year":"2023","journal-title":"Immunity"},{"issue":"49","key":"10.1016\/j.cytogfr.2026.06.004_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba7918","article-title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells","volume":"5","author":"Sekine","year":"2020","journal-title":"Sci. Immunol."},{"issue":"7926","key":"10.1016\/j.cytogfr.2026.06.004_bib74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41586-022-05105-1","article-title":"MYB orchestrates T cell exhaustion and response to checkpoint inhibition","volume":"609","author":"Tsui","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.06.004_bib75","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41590-021-00964-8","article-title":"BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells","volume":"22","author":"Seo","year":"2021","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","article-title":"An HIF-1alpha\/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression","volume":"32","author":"Palazon","year":"2017","journal-title":"Cancer Cell."},{"issue":"6316","key":"10.1016\/j.cytogfr.2026.06.004_bib77","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"issue":"7655","key":"10.1016\/j.cytogfr.2026.06.004_bib78","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature22367","article-title":"Chromatin states define tumour-specific T cell dysfunction and reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"issue":"620","key":"10.1016\/j.cytogfr.2026.06.004_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0272","article-title":"Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity","volume":"13","author":"Prinzing","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib80","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2017.03.012","article-title":"Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8(+) T Cell Terminal Differentiation and Loss of Multipotency","volume":"46","author":"Gray","year":"2017","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib81","article-title":"Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells","volume":"217","author":"Tay","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib82","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1038\/s41467-021-27179-7","article-title":"LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib83","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1038\/s41467-024-48607-4","article-title":"Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells","volume":"15","author":"Qiu","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib84","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41467-024-52528-7","article-title":"Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial","volume":"15","author":"Baretti","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib86","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/imm.13575","article-title":"Metabolic plasticity and regulation of T cell exhaustion","volume":"167","author":"Li","year":"2022","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib87","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41419-023-05937-3","article-title":"Effects of altered glycolysis levels on CD8(+) T cell activation and function","volume":"14","author":"Cao","year":"2023","journal-title":"Cell. Death Dis."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib88","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.it.2014.12.005","article-title":"Fatty acid metabolism in the regulation of T cell function","volume":"36","author":"Lochner","year":"2015","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib89","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib90","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib91","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib92","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.06.004_bib93","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1136\/gutjnl-2022-328734","article-title":"Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8(+) T cells","volume":"72","author":"Winkler","year":"2023","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1731","article-title":"Harnessing CD8(+) T cell dynamics in hepatitis B virus-associated liver diseases: insights, therapies and future directions","volume":"14","author":"Yue","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib95","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12865-022-00488-2","article-title":"Exhausted phenotype of circulating CD8(+) T cell subsets in hepatitis B virus carriers","volume":"23","author":"Jiang","year":"2022","journal-title":"BMC Immunol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib96","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cmet.2020.11.004","article-title":"Mitochondrial damage and the road to exhaustion","volume":"32","author":"Li","year":"2020","journal-title":"Cell. Metab."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib97","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s42255-019-0081-4","article-title":"Metabolic plasticity of HIV-specific CD8(+) T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection","volume":"1","author":"Angin","year":"2019","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib98","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib99","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib101","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib102","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"issue":"3-4","key":"10.1016\/j.cytogfr.2026.06.004_bib103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00430-019-00608-7","article-title":"The hallmarks of CMV-specific CD8 T-cell differentiation","volume":"208","author":"van den Berg","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"issue":"7109","key":"10.1016\/j.cytogfr.2026.06.004_bib104","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cytogfr.2026.06.004_bib105","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.06.004_bib106","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib107","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib108","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1038\/s41467-020-18256-4","article-title":"Exhausted CD8(+) T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection","volume":"11","author":"Sandu","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib109","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.4049\/jimmunol.0800997","article-title":"Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion","volume":"182","author":"Bucks","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib110","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad514","article-title":"T-Cell Exhaustion in HIV-1\/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C","volume":"10","author":"Caraballo Cort\u00e9s","year":"2023","journal-title":"Open. Forum Infect. Dis."},{"issue":"6230","key":"10.1016\/j.cytogfr.2026.06.004_bib111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib112","article-title":"New emerging targets in cancer immunotherapy: the role of neoantigens","volume":"4","author":"De Mattos-Arruda","year":"2020","journal-title":"ESMO Open."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-Specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.cytogfr.2026.06.004_bib114","doi-asserted-by":"crossref","first-page":"E2776","DOI":"10.1073\/pnas.1620498114","article-title":"Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells","volume":"114","author":"Mognol","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6024","key":"10.1016\/j.cytogfr.2026.06.004_bib115","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"issue":"7528","key":"10.1016\/j.cytogfr.2026.06.004_bib116","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"issue":"6477","key":"10.1016\/j.cytogfr.2026.06.004_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41590-021-00898-1","article-title":"Multi-omics analyses reveal that HIV-1 alters CD4(+) T cell immunometabolism to fuel virus replication","volume":"22","author":"Guo","year":"2021","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib119","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101081","article-title":"Elevated glycolysis imparts functional ability to CD8(+) T cells in HIV infection","volume":"4","author":"Rahman","year":"2021","journal-title":"Life Sci. Alliance"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s12250-021-00433-4","article-title":"Influenza A Virus (H1N1) infection induces glycolysis to facilitate viral replication","volume":"36","author":"Ren","year":"2021","journal-title":"Virol. Sin."},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib121","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/15548627.2021.1990515","article-title":"Newcastle disease virus degrades SIRT3 via PINK1-PRKN-dependent mitophagy to reprogram energy metabolism in infected cells","volume":"18","author":"Gong","year":"2022","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib122","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/JVI.02309-14","article-title":"Dengue virus induces and requires glycolysis for optimal replication","volume":"89","author":"Fontaine","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-981-10-5765-6_6","article-title":"EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma","volume":"1018","author":"Zhang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib124","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1\u03b1\/Glycolysis-Dependent Axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell. Metab."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib125","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1128\/JVI.01759-12","article-title":"Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals","volume":"87","author":"Qin","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2012.03.041","article-title":"Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells","volume":"143","author":"Sandalova","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib127","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib128","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2026.06.004_bib129","article-title":"Metabolomic Profiling Reveals Potential of Fatty Acids as Regulators of Stem-like Exhausted CD8 T Cells During Chronic Viral Infection","author":"Kazane","year":"2024","journal-title":"bioRxiv"},{"issue":"6468","key":"10.1016\/j.cytogfr.2026.06.004_bib130","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"issue":"6-7","key":"10.1016\/j.cytogfr.2026.06.004_bib131","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib132","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodriguez","year":"2008","journal-title":"Immunol. Rev."},{"issue":"1-2","key":"10.1016\/j.cytogfr.2026.06.004_bib133","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cellimm.2005.01.004","article-title":"L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes","volume":"232","author":"Zea","year":"2004","journal-title":"Cell. Immunol."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib134","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"issue":"7368","key":"10.1016\/j.cytogfr.2026.06.004_bib135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib136","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","article-title":"PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8(+) T Cells and Facilitates Anti-PD-1 Therapy","volume":"6","author":"Chowdhury","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib137","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8(+) T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell. Metab."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib139","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib140","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1956143","article-title":"Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma","volume":"10","author":"Sosnowska","year":"2021","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.06.004_bib141","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib142","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41467-020-20316-8","article-title":"Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition","volume":"12","author":"Zhou","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103300","article-title":"Influenza A induces lactate formation to inhibit type I IFN in primary human airway epithelium","volume":"24","author":"Thyrsted","year":"2021","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002202","article-title":"Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions","volume":"13","author":"Haas","year":"2015","journal-title":"PLoS. Biol."},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib145","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res."},{"issue":"42","key":"10.1016\/j.cytogfr.2026.06.004_bib146","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1038\/onc.2017.188","article-title":"Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells","volume":"36","author":"Feng","year":"2017","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib147","first-page":"5726","article-title":"Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8(+) cytolytic T cells","volume":"11","author":"Chen","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"12","key":"10.1016\/j.cytogfr.2026.06.004_bib148","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","article-title":"Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism","volume":"25","author":"Peralta","year":"2024","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cytogfr.2026.06.004_bib149","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s42255-022-00730-6","article-title":"Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness","volume":"5","author":"Cheng","year":"2023","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib150","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8\u2009+\u2009T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660944","article-title":"Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells","volume":"12","author":"Bannoud","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cytogfr.2026.06.004_bib152","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150846","article-title":"Targeting HIF-1alpha abrogates PD-L1-mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues","volume":"132","author":"Bailey","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib153","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","article-title":"Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity","volume":"7","author":"Miret","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib154","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"74","key":"10.1016\/j.cytogfr.2026.06.004_bib156","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj9123","article-title":"Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells","volume":"7","author":"Ford","year":"2022","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib157","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1038\/s41467-025-59529-0","article-title":"SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases","volume":"16","author":"Trehan","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.06.004_bib158","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.cytogfr.2026.06.004_bib159","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.cytogfr.2026.06.004_bib160","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6332","key":"10.1016\/j.cytogfr.2026.06.004_bib161","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.aaf0683","article-title":"Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent","volume":"355","author":"Kamphorst","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cytogfr.2026.06.004_bib162","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 Agonist Antibodies in Cancer Immunotherapy","volume":"71","author":"Vonderheide","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib163","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3389\/fimmu.2018.00866","article-title":"Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer","volume":"9","author":"Marelli","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib164","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3389\/fimmu.2019.01848","article-title":"Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study","volume":"10","author":"Marchini","year":"2019","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.cytogfr.2026.06.004_bib165","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1158\/1078-0432.CCR-18-0945","article-title":"Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors","volume":"24","author":"Margolin","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib166","first-page":"1027","article-title":"Effects of IL-7 on memory CD8 T cell homeostasis are influenced by the timing of therapy in mice","volume":"118","author":"Nanjappa","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib167","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib168","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","article-title":"Global manufacturing of CAR T cell therapy","volume":"4","author":"Levine","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"5","key":"10.1016\/j.cytogfr.2026.06.004_bib169","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/21645515.2019.1571893","article-title":"CRISPR\/Cas9-based genome editing in the era of CAR T cell immunotherapy","volume":"15","author":"Salas-Mckee","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"issue":"14","key":"10.1016\/j.cytogfr.2026.06.004_bib170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142519","article-title":"B7H4 role in solid cancers: a review of the literature","volume":"16","author":"Dawidowicz","year":"2024","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.cytogfr.2026.06.004_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235983","article-title":"Efficacy, safety, and challenges of CAR T-cells in the treatment of solid tumors","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.cytogfr.2026.06.004_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103295","article-title":"Effective chimeric antigen receptor T cells against SARS-CoV-2","volume":"24","author":"Guo","year":"2021","journal-title":"iScience"},{"issue":"19","key":"10.1016\/j.cytogfr.2026.06.004_bib173","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150211","article-title":"Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1","volume":"131","author":"Liu","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib174","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cytogfr.2026.06.004_bib175","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2014-308316","article-title":"Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein","volume":"65","author":"Sautto","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib176","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7555\/JBR.28.20140066","article-title":"T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo","volume":"28","author":"Tang","year":"2014","journal-title":"J. Biomed. Res."},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib177","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib178","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcell.2020.00017","article-title":"T Cell Dysfunction and Exhaustion in Cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib179","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.cytogfr.2026.06.004_bib180","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2026.06.004_bib181","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"issue":"7620","key":"10.1016\/j.cytogfr.2026.06.004_bib182","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cytogfr.2026.06.004_bib183","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cytogfr.2026.06.004_bib184","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.2606","article-title":"T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion","volume":"14","author":"Utzschneider","year":"2013","journal-title":"Nat. Immunol."},{"issue":"629","key":"10.1016\/j.cytogfr.2026.06.004_bib185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl3836","article-title":"Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy","volume":"14","author":"Uldrick","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"1-2","key":"10.1016\/j.cytogfr.2026.06.004_bib186","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2018.12.034","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"176","author":"Sade-Feldman","year":"2019","journal-title":"Cell"},{"issue":"41","key":"10.1016\/j.cytogfr.2026.06.004_bib187","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221985120","article-title":"Characteristics and anatomic location of PD-1(+)TCF1(+) stem-like CD8 T cells in chronic viral infection and cancer","volume":"120","author":"Im","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.cytogfr.2026.06.004_bib188","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.cytogfr.2026.06.004_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114392","article-title":"Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy","volume":"43","author":"Quek","year":"2024","journal-title":"Cell. Rep."},{"issue":"1","key":"10.1016\/j.cytogfr.2026.06.004_bib190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","article-title":"Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"issue":"8","key":"10.1016\/j.cytogfr.2026.06.004_bib191","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610126000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:10:51Z","timestamp":1785877851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610126000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":191,"alternative-id":["S1359610126000468"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.06.004","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shared and context-specific mechanisms of T cell exhaustion in chronic viral infections and cancer: Transcriptional, metabolic, epigenetic, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}